HIV-Specific T Cell Responses in Rectal Mucosa

描述（由申请人提供）：由于胃肠道粘膜是病毒复制和CD4 t细胞耗竭的关键早期部位，也是体内最大的淋巴器官，因此评估在该组织中发挥作用的适应性免疫机制可能为我们理解宿主-病原体关系提供重要的新见解。在之前的资助周期中，我们的研究表明，在慢性HIV感染期间，肠道粘膜中出现了强大的、通常是多功能的CD8 t细胞反应。在下一个资助周期中，我们将以先前的研究为基础，测试关于粘膜免疫在HIV发病机制中的作用的三个互补假设。我们的研究将集中在(1)多功能粘膜t细胞作为非进展的免疫相关；(2)抗逆转录病毒治疗（ART）对肠道CD8 t细胞表型和功能的影响；(3)粘膜调节性t细胞在形成多功能适应性免疫应答中的作用。这些研究将对接受和不接受抗逆转录病毒治疗的艾滋病毒阳性受试者的成对血液和粘膜样本进行，包括一组特征明确的艾滋病毒控制者和健康对照者。在特异性目标1中，我们将检验粘膜组织中多功能的hiv特异性CD8 t细胞是不进展的免疫相关的假设。为了本研究的目的，我们将多功能T细胞定义为那些能够分泌多种细胞因子/趋化因子并在体外刺激下释放细胞溶解颗粒的细胞。我们的假设预测，精英控制者（EC，病毒载量<75）和病毒血症控制者（VC，病毒载量75- 2000）的粘膜t细胞反应比非控制者（NC，病毒载量100 000）的粘膜t细胞反应更强，功能更复杂，范围更广。对于具体目标2，我们将重点关注正在开始ART的非控制者。我们将验证以下假设：(a)肠道微环境驱动病毒特异性记忆CD8+ t细胞由于高抗原负荷、CD4 t细胞耗竭和PD- 1配体的局部表达而导致免疫衰老；(b)抗逆转录病毒治疗只会导致部分CD4细胞的恢复和肠道免疫衰老的逆转。最后，在Specific Aim 3中，我们将验证调节性t细胞存在于hiv感染个体的粘膜组织中的假设，并且这些细胞在粘膜组织中局部作用以抑制hiv特异性效应功能。综上所述，这些研究将极大地促进我们对慢性感染期间粘膜组织中hiv -宿主关系的理解。

DESCRIPTION (provided by applicant): Because the gastrointestinal mucosa is a critical early site of viral replication and CD4 T-cell depletion, as well as the largest lymphoid organ in the body, assessment of the adaptive immune mechanisms functioning in this tissue may provide important new insights relevant to our understanding of the host-pathogen relationship. Our studies during the prior funding cycle indicated that a robust, often polyfunctional CD8 T-cell response is mounted in gut mucosa during chronic HIV infection. In the next funding cycle, we will build upon prior studies to test three complementary hypotheses concerning the role of mucosal immunity in HIV pathogenesis. Our studies will focus on (1) Polyfunctional mucosal T-cells as an immune correlate of non-progression; (2) The effects of antiretroviral therapy (ART) on CD8 T-cell phenotype and function in the gut; and (3) The role of mucosal regulatory T-cells in shaping polyfunctional adaptive immune responses. These studies will be conducted on paired blood and mucosal samples from HIV+ subjects on and off ART, including a well-characterized group of HIV controllers, and healthy controls. In Specific Aim 1, we will test the hypothesis that polyfunctional, HIV-specific CD8 T-cells in mucosal tissues are an immune correlate of non-progression. For the purposes of this study, we define polyfunctional T cells as those capable of secreting multiple cytokines/chemokines and releasing cytolytic granules upon in vitro stimulation. Our hypothesis predicts that mucosal T-cell responses in individuals characterized as Elite Controllers (EC, viral load <75) and Viremic Controllers (VC, viral load 75-2,000) are stronger, more functionally complex, and broader than in Non-Controllers (NC, viral load >10,000). For Specific Aim 2, we will focus on Non-Controllers who are beginning ART. We will test the hypotheses that (a) the gut microenvironment drives virus-specific memory CD8+ T-cells to immune senescence due to high antigen load, CD4 T-cell depletion, and local expression of ligands for PD- 1; and (b) ART will lead to only partial CD4 restoration and reversal of immune senescence in the gut. Finally, for Specific Aim 3, we will test the hypothesis that regulatory T-cells are present in mucosal tissues of HIV-infected individuals, and that these cells act locally within mucosal tissues to suppress HIV-specific effector functions. Taken together, these studies should greatly advance our understanding of the HIV-host relationship in mucosal tissues during chronic infection.